Literature DB >> 9706424

Detection and modification of risk factors for coronary artery disease in patients with systemic lupus erythematosus: a quality improvement study.

I N Bruce1, D D Gladman, M B Urowitz.   

Abstract

OBJECTIVE: To assess the detection and control of risk factors for atherosclerosis in patients with SLE who subsequently develop acute coronary events.
METHODS: Patients followed at the University of Toronto Lupus Clinic who developed a myocardial infarction (MI) or acute coronary insufficiency (ACI) and who had 2 years of follow-up prior to their event were identified and their case notes reviewed. The management of potentially reversible risk factors in this cohort was assessed.
RESULTS: Twenty-four patients (18 female, 6 male) were studied. The mean age at the coronary event was 50 years and the mean duration of SLE was 13.5 years. Nineteen patients had MI and 5 had ACI. Risk factors identified were hypertension (16), obesity/Cushing's (19), smoking (16), hypercholesterolaemia (11), steroid use (22), hyperglycaemia (4) and cardiac involvement with SLE (4). In the two years prior to the event, hypertension and cardiac involvement were appropriately managed in almost all cases. Sixty percent had attempts made to reduce or stop their steroid therapy. Two of four cases with hyperglycaemia and 5 of 11 patients with hypercholesterolaemia had no appropriate action noted. No smoking advice was recorded, while one obese patient had weight reduction advice recorded.
CONCLUSION: SLE patients who develop coronary events have potentially reversible risk factors prior to the event. Rheumatologists perform well when optimizing the control of SLE, minimizing the steroid dose and managing hypertension. Other risk factors are less favorably managed. Physicians managing lupus patients need to play a primary role in screening for and managing cardiac risk factors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9706424

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  15 in total

1.  Racial disparities in age at time of cardiovascular events and cardiovascular-related death in patients with systemic lupus erythematosus.

Authors:  Lisabeth V Scalzi; Christopher S Hollenbeak; Li Wang
Journal:  Arthritis Rheum       Date:  2010-09

Review 2.  The role of preventive cardiology in systemic lupus erythematosus.

Authors:  Jennifer Rae Elliott; Susan Manzi; Daniel Edmundowicz
Journal:  Curr Rheumatol Rep       Date:  2007-05       Impact factor: 4.592

Review 3.  Revisiting the issue of malignancy risk in systemic lupus erythematosus.

Authors:  Sasha Bernatsky; Rosalind Ramsey-Goldman; Ann E Clarke
Journal:  Curr Rheumatol Rep       Date:  2005-12       Impact factor: 4.592

4.  Modification of hypertension and hypercholesterolaemia in patients with systemic lupus erythematosus: a quality improvement study.

Authors:  M B Urowitz; D D Gladman; D Ibanez; Y Berliner
Journal:  Ann Rheum Dis       Date:  2006-01       Impact factor: 19.103

5.  Osteoporosis and cardiovascular disease care in systemic lupus erythematosus according to new quality indicators.

Authors:  Kristina L Demas; Brendan T Keenan; Daniel H Solomon; Jinoos Yazdany; Karen H Costenbader
Journal:  Semin Arthritis Rheum       Date:  2010-04-08       Impact factor: 5.532

Review 6.  [Accelerated atherosclerosis in rheumatic systemic diseases as an example of systemic lupus erythematosus--what is the consequence?].

Authors:  R Fischer-Betz; S Beer; M Schneider
Journal:  Z Rheumatol       Date:  2005-05       Impact factor: 1.372

Review 7.  Malignancy and systemic lupus erythematosus.

Authors:  Sasha Bernatsky; Ann Clarke; Rosalind Ramsey-Goldman
Journal:  Curr Rheumatol Rep       Date:  2002-08       Impact factor: 4.592

8.  Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California.

Authors:  Arti Parikh-Patel; Richard H White; Mark Allen; Rosemary Cress
Journal:  Cancer Causes Control       Date:  2008-04-02       Impact factor: 2.506

9.  Application of a nomogram for exercise capacity in women with systemic lupus erythematosus.

Authors:  E M Hazel; S Bernatsky; D Da Costa; K Dasgupta; A E Clarke; L Joseph; Y St Pierre; C A Pineau
Journal:  Clin Rheumatol       Date:  2009-02-17       Impact factor: 2.980

Review 10.  Pragmatic approaches to therapy for systemic lupus erythematosus.

Authors:  Wen Xiong; Robert G Lahita
Journal:  Nat Rev Rheumatol       Date:  2013-10-29       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.